Planas-Ballvé, A.; Caballol Pons, N.; Peral Quirós, A.; Gómez Ruiz, I.; Balagué Marmaña, M.; Velázquez Ballester, A.J.; Lozano Moreno, D.; Ávila Rivera, A.
Long-Term Real-World Experience with Safinamide in Patients with Parkinson’s Disease. Brain Sci. 2024, 14, 1238.
https://doi.org/10.3390/brainsci14121238
AMA Style
Planas-Ballvé A, Caballol Pons N, Peral Quirós A, Gómez Ruiz I, Balagué Marmaña M, Velázquez Ballester AJ, Lozano Moreno D, Ávila Rivera A.
Long-Term Real-World Experience with Safinamide in Patients with Parkinson’s Disease. Brain Sciences. 2024; 14(12):1238.
https://doi.org/10.3390/brainsci14121238
Chicago/Turabian Style
Planas-Ballvé, Anna, Núria Caballol Pons, Alejandro Peral Quirós, Isabel Gómez Ruiz, Marta Balagué Marmaña, Alexander J. Velázquez Ballester, Dolors Lozano Moreno, and Asunción Ávila Rivera.
2024. "Long-Term Real-World Experience with Safinamide in Patients with Parkinson’s Disease" Brain Sciences 14, no. 12: 1238.
https://doi.org/10.3390/brainsci14121238
APA Style
Planas-Ballvé, A., Caballol Pons, N., Peral Quirós, A., Gómez Ruiz, I., Balagué Marmaña, M., Velázquez Ballester, A. J., Lozano Moreno, D., & Ávila Rivera, A.
(2024). Long-Term Real-World Experience with Safinamide in Patients with Parkinson’s Disease. Brain Sciences, 14(12), 1238.
https://doi.org/10.3390/brainsci14121238
